ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
36 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
36
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
7 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Guess the RAC220 patent lodgement date
|
|
optic
|
41 |
9.4K |
8 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
41
|
9.4K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: December 2023 Preclinical & Clinical Program Update
|
|
optic
|
66 |
20K |
16 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
66
|
20K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
optic
|
93 |
24K |
20 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
93
|
24K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
AML Diagnosis - things to know
|
|
optic
|
10 |
4.0K |
67 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
10
|
4.0K
|
67
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
optic
|
153 |
48K |
37 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
153
|
48K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene AML trial in Israel advances to Phase 2
|
|
optic
|
233 |
81K |
15 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
233
|
81K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
17 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
20K
|
6.9M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
optic
|
268 |
80K |
16 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
268
|
80K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
optic
|
268 |
80K |
20 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
268
|
80K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
optic
|
2.0K |
668K |
18 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
2.0K
|
668K
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
optic
|
10K |
3.7M |
13 |
03/05/23 |
03/05/23 |
General
|
10K
|
3.7M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
optic
|
10K |
3.7M |
3 |
03/05/23 |
03/05/23 |
General
|
10K
|
3.7M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
optic
|
133 |
38K |
23 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
133
|
38K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race continues Board renewal - appoints new Chair
|
|
optic
|
102 |
33K |
86 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
102
|
33K
|
86
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
optic
|
559 |
178K |
44 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
559
|
178K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
optic
|
559 |
178K |
13 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
559
|
178K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
optic
|
559 |
178K |
2 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
178K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
optic
|
559 |
178K |
45 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
178K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
optic
|
559 |
178K |
32 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
178K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
optic
|
196 |
69K |
0 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
196
|
69K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
optic
|
42 |
12K |
23 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
42
|
12K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
23 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
20K
|
6.9M
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
5 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
optic
|
10K |
3.7M |
15 |
21/01/23 |
21/01/23 |
General
|
10K
|
3.7M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
optic
|
46 |
15K |
36 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
46
|
15K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Melbourne Investor Briefing Invitation
|
|
optic
|
70 |
24K |
58 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
70
|
24K
|
58
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
optic
|
10K |
3.7M |
5 |
17/10/22 |
17/10/22 |
General
|
10K
|
3.7M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
optic
|
43 |
16K |
3 |
08/10/22 |
08/10/22 |
ASX - By Stock
|
43
|
16K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates New Drug Discovery Program
|
|
optic
|
51 |
19K |
8 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
51
|
19K
|
8
|
|
ASX - By Stock
|
ADN |
Re:
ADN- PEPR ENVIRONMENTAL LODGED
|
|
optic
|
47 |
16K |
24 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
47
|
16K
|
24
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda signs Binding Halloysite-Kaolin Offtake Term Sheet
|
|
optic
|
196 |
86K |
14 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
196
|
86K
|
14
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda signs Binding Halloysite-Kaolin Offtake Term Sheet
|
|
optic
|
196 |
86K |
20 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
196
|
86K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene data published in Cancer Research Journal
|
|
optic
|
38 |
14K |
5 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
38
|
14K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
16 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
20K
|
6.9M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
optic
|
215 |
71K |
10 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
215
|
71K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
4 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
20K
|
6.9M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
6 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
20K
|
6.9M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
optic
|
26 |
7.1K |
10 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
26
|
7.1K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
2 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
20K
|
6.9M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
optic
|
47 |
19K |
3 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
47
|
19K
|
3
|
|
ASX - By Stock
|
CRL |
Re:
International Graphite IPO
|
|
optic
|
81 |
33K |
3 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
81
|
33K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Supply Agreement for EMD AML Trial
|
|
optic
|
75 |
31K |
29 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
75
|
31K
|
29
|
|
ASX - By Stock
|
IG6 |
Re:
International Graphite IPO
|
|
optic
|
271 |
137K |
4 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
271
|
137K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
optic
|
20K |
6.9M |
6 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
20K
|
6.9M
|
6
|
|
ASX - By Stock
|
IG6 |
Re:
International Graphite IPO
|
|
optic
|
271 |
137K |
6 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
271
|
137K
|
6
|
|
ASX - By Stock
|
SRN |
Re:
Ann: Perenjori Iron Proj Negotiations for Offtake and Infrastruct
|
|
optic
|
323 |
103K |
10 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
323
|
103K
|
10
|
|
ASX - By Stock
|
ADN |
Re:
The Future of ADN?
|
|
optic
|
6 |
3.0K |
11 |
05/03/22 |
05/03/22 |
ASX - By Stock
|
6
|
3.0K
|
11
|
|